Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001590501-17-000001
Filing Date
2017-07-25
Accepted
2017-07-25 11:52:45
Documents
1
Effectiveness Date
2017-07-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13486
  Complete submission text file 0001590501-17-000001.txt   14507
Mailing Address 30 SPRING MILL DRIVE MALVERN PA 19355
Business Address 30 SPRING MILL DRIVE MALVERN PA 19355 610-644-8935
VenatoRx Pharmaceuticals, Inc. (Filer) CIK: 0001590501 (see all company filings)

EIN.: 272782193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-291424 | Film No.: 17979884